Pericardial tamponade during pembrolizumab treatment in a patient with advanced lung adenocarcinoma: A case report and review of the literature

Several studies have demonstrated increased pericardial effusion during anti‐PD‐1 immunotherapy, and treatment in patients who have developed pericardial tamponade is controversial. In this study, we describe a 63‐year‐old woman with stage IVA lung adenocarcinoma given pembrolizumab as a first‐line...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Kazuaki, Ogasawara, Makoto, Shido, Akane, Meno, Akimitsu, Oda, Soichiro, Yoshida, Shota, Yoshida, Sonoe, Yoshikawa, Ayumu, Ebata, Ko, Abiko, Satoshi, Kawagishi, Naoki, Sano, Itsuki, Oda, Hisashi, Miyagishima, Takuto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180565/
https://www.ncbi.nlm.nih.gov/pubmed/32181993
http://dx.doi.org/10.1111/1759-7714.13399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180565/
https://www.ncbi.nlm.nih.gov/pubmed/32181993
http://dx.doi.org/10.1111/1759-7714.13399

Ejemplares similares